Brazil's Health Ministry on Friday approved use of Sinovac Biotech Ltd's (SVA.O) COVID-19 vaccine, Coronavac, for children ages 6 to 17. In a news conference announcing the addition of Coronavac to the national vaccination plan, Deputy Health Minister Rodrigo Cruz said the ministry has 6 million doses of the vaccine available, with states and cities having their own stocks. The Chinese vaccine was tested in Brazil at Sao Paulo's Butantan Institute, a leading biomedical center tied to the state government. Coronavac received authorization for emergency use in adults in January last year and was the first vaccine to be used in Brazil. Later, however, it was supplanted by other shots and is no longer being used in adults. Brazil has already authorized the Pfizer (PFE.N)/BioNTech vaccine for children between 5 and 11 years old.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!